Communiqués Asahi Kasei Corporation OTC Markets

Actions

AHKSY

US0434001006

Chimie diversifiée

Marché Fermé - OTC Markets 21:57:15 18/09/2026			Varia. 5j.	Varia. 1 janv.
20,30 ^USD	-2,12%		-0,10%	+14,73%

15/09	Asahi Kasei Bioprocess dévoile le Vantij Su-Vfc Benchtop pour la filtration virale automatisée à usage unique	CI
14/09	Une filiale d'Asahi Kasei lance une étude de phase II sur l'antifongique Cresemba pour les patients pédiatriques au Japon	MT

Communiqués

17/09	Asahi Kasei : Statement on arrest of former employee	PU
15/09	Asahi Kasei Introduces VANTIJ® SU-VFC Benchtop to Improve Efficiency and Consistency in Gene Therapy Manufacturing	BU
15/09	Asahi Kasei : Introduces VANTIJ® SU-VFC Benchtop to Improve Efficiency and Consistency in Gene Therapy Manufacturing	PU
14/09	Asahi Kasei : Begins Phase II Clinical Trial of isavuconazonium sulfate for Pediatric Patients in Japan	PU
08/09	Asahi Kasei Microdevices’ CZ39 and CZ3K Current Sensors Featured in Microchip Technology’s Machine Learning-Based Arc Fault Detection Reference Design	BU
08/09	Asahi Kasei : Microdevices’ CZ39 and CZ3K Current Sensors Featured in Microchip Technology’s Machine Learning-Based Arc Fault Detection Reference Design	PU
01/09	Asahi Kasei : Veloxis Pharmaceuticals Doses First Patient in RENGEVITY-201 Phase 2 Trial of Pegrizeprument for the Prevention of Organ Rejection in Kidney Transplant Recipients	PU
26/08	Asahi Kasei Unveils New Wet-Process Separator Coating Line in North Carolina, Advancing the Company’s 40-Year North American Battery Separator Strategy	BU
26/08	Asahi Kasei : Unveils New Wet-Process Separator Coating Line in North Carolina, Advancing the Company’s 40-Year North American Battery Separator Strategy	PU
24/08	Asahi Kasei : Empaveli™ Approved in Japan for Additional Rare Kidney Disease Indications of C3 Glomerulopathy and Primary Immune Complex Membranoproliferative Glomerulonephritis	PU
24/08	Asahi Kasei : Contract Signed with JOGMEC for Design Work Related to Ship-Based Advanced CCS Project	PU
20/08	Asahi Kasei's Capacity Expansion for Water Electrolysis and Chlor-Alkali Equipment in Kawasaki Awarded Regional Economic Incentives	AQ
20/08	Asahi Kasei Develops Novel Lithium Pre-doping Technology to Raise Energy Density and Lower Cost of Silicon-rich Lithium-ion Batteries	BU
20/08	Asahi Kasei Develops Novel Lithium Pre-doping Technology to Raise Energy Density and Lower Cost of Silicon-rich Lithium-ion Batteries	BU
20/08	Asahi Kasei : Develops Novel Lithium Pre-doping Technology to Raise Energy Density and Lower Cost of Silicon-rich Lithium-ion Batteries	PU
19/08	Asahi Kasei’s Capacity Expansion for Water Electrolysis and Chlor‑Alkali Equipment in Kawasaki Awarded Regional Economic Incentives	BU
19/08	Asahi Kasei : Capacity Expansion for Water Electrolysis and Chlor‑Alkali Equipment in Kawasaki Awarded Regional Economic Incentives	PU
18/08	Asahi Kasei : selected for continued inclusion in the ESG indices FTSE4Good Index Series, FTSE JPX Blossom Japan Index, and FTSE JPX Blossom Japan Sector Relative Index	PU
17/08	Asahi Kasei : Results and completion of repurchase of shares	PU
06/08	Asahi Kasei Enters First License Agreement for Production and Sale of Acetolyte™ Novel Electrolyte in China	BU
06/08	Asahi Kasei : Enters First License Agreement for Production and Sale of Acetolyte™ Novel Electrolyte in China	PU
03/08	Asahi Kasei : Notice regarding status of share repurchase	PU
31/07	Asahi Kasei : Financial Results Presentation Material, first quarter fiscal 2026	PU
15/07	Asahi Kasei Microdevices Begins Mass Production of Camera‑less Modules for Detection of Falls, Vital Signs, Posture, and Position	BU
08/07	Asahi Kasei : Home Order Trends – June 2026	PU